CRYO CELL INTERNATIONAL INC
For the period ended May 31, 2024. Filed Jul 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
May 31, 2024 · Filed Jul 15, 2024
CCEL$4.87-0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
| For the Three Months Ended | For the Six Months Ended | |||
|---|---|---|---|---|
| May 31, | May 31, | May 31, | May 31, | |
| 2024 | 2023 | 2024 | 2023 | |
| Revenue: | ||||
| Processing and storage fees | $7,965,500 | $7,581,697 | $15,771,022 | $15,143,215 |
| Public banking revenue | 41,477 | 163,816 | 85,190 | 394,513 |
| Product revenue | 35,834 | 27,177 | 38,834 | 59,377 |
| Total revenue | 8,042,811 | 7,772,690 | 15,895,046 | 15,597,105 |
| Costs and Expenses: | ||||
| Cost of sales | 2,024,750 | 2,143,186 | 4,185,218 | 4,210,550 |
| Selling, general and administrative expenses | 4,021,357 | 4,038,968 | 8,361,002 | 7,917,871 |
| Impairment of investment - Tianhe stock | 308,000 | — | 308,000 | — |
| Change in fair value of contingent consideration | (3,697) | (23,124) | (8,873) | (187,825) |
| Research, development and related engineering | 241,085 | 304,682 | 743,974 | 383,516 |
| Depreciation and amortization | 59,798 | 281,080 | 92,984 | 561,924 |
| Total costs and expenses | 6,651,293 | 6,744,792 | 13,682,305 | 12,886,036 |
| Operating Income | 1,391,518 | 1,027,898 | 2,212,741 | 2,711,069 |
| Other Income (Expense): | ||||
| Gains on marketable securities | 258,623 | 10,377 | 533,594 | 6,696 |
| Gain (loss) on interest rate swap | 151,175 | (223,974) | 105,887 | (223,974) |
| Other income | 137 | 2,066 | 200 | 3,334 |
| Interest expense | (329,273) | (469,952) | (585,732) | (936,183) |
| Total other income (expense) | 80,662 | (681,483) | 53,949 | (1,150,127) |
| Income before income tax expense | 1,472,180 | 346,415 | 2,266,690 | 1,560,942 |
| Income tax expense | (816,390) | (125,439) | (1,054,659) | (573,154) |
| Net income | $655,790 | $220,976 | $1,212,031 | $987,788 |
| Net income per common share - basic | $0.08 | $0.03 | $0.15 | $0.12 |
| Weighted average common shares outstanding - basic | 8,117,479 | 8,325,101 | 8,197,223 | 8,395,307 |
| Net income per common share - diluted | $0.08 | $0.03 | $0.15 | $0.12 |
| Weighted average common shares outstanding - diluted | 8,232,327 | 8,331,911 | 8,275,414 | 8,402,538 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.